Cargando…
Prognostic Value of CD200R1 mRNA Expression in Head and Neck Squamous Cell Carcinoma
Immune system dysfunction is associated with head and neck squamous cell carcinoma (HNSCC) development and progression and immune checkpoint inhibitors have demonstrated substantial survival benefits in platinum-refractory HNSCC; therefore, we examined the prognostic value of immune-related gene (IR...
Autores principales: | Chang, Hyun, Lee, Yun-Gyoo, Ko, Yoon Ho, Cho, Jang Ho, Choi, Jong-Kwon, Park, Keon Uk, Kang, Eun Joo, Lee, Keun-Wook, Lim, Sun Min, Kim, Jin-Soo, Lee, Hyun Woo, Kim, Min Kyoung, Hwang, In Gyu, Kim, Sangwoo, Nam, Byung-Ho, Kim, Hye Ryun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408128/ https://www.ncbi.nlm.nih.gov/pubmed/32635224 http://dx.doi.org/10.3390/cancers12071777 |
Ejemplares similares
-
Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12
por: Lee, Yun-Gyoo, et al.
Publicado: (2021) -
Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma
por: Lim, Sun Min, et al.
Publicado: (2019) -
Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13–01)
por: Lee, Yun-Gyoo, et al.
Publicado: (2020) -
Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01)
por: Lee, Yun-Gyoo, et al.
Publicado: (2023) -
Induction Chemotherapy as a Prognostication Index and Guidance for Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: The Concept of Chemo-Selection (KCSG HN13-01)
por: Lee, Yun-Gyoo, et al.
Publicado: (2022)